OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
Marc Aurel Busche, Susanne Wegmann, Simon Dujardin, et al.
Nature Neuroscience (2018) Vol. 22, Iss. 1, pp. 57-64
Open Access | Times Cited: 365

Showing 1-25 of 365 citing articles:

Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1489

Synergy between amyloid-β and tau in Alzheimer’s disease
Marc Aurel Busche, Bradley T. Hyman
Nature Neuroscience (2020) Vol. 23, Iss. 10, pp. 1183-1193
Closed Access | Times Cited: 856

The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
Jerrah K. Holth, Sarah K. Fritschi, Chanung Wang, et al.
Science (2019) Vol. 363, Iss. 6429, pp. 880-884
Open Access | Times Cited: 605

Amyloid-β-independent regulators of tau pathology in Alzheimer disease
Rik van der Kant, Lawrence S.B. Goldstein, Rik Ossenkoppele
Nature reviews. Neuroscience (2019) Vol. 21, Iss. 1, pp. 21-35
Closed Access | Times Cited: 443

Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Yun Zhang, Huaqiu Chen, Ran Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 358

Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
Tim Bartels, Sebastiaan De Schepper, Soyon Hong
Science (2020) Vol. 370, Iss. 6512, pp. 66-69
Open Access | Times Cited: 309

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang, Wei Wei, Ming Zhao, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2181-2192
Open Access | Times Cited: 292

New Insights Into the Pathogenesis of Alzheimer's Disease
Liyuan Fan, Chengyuan Mao, Xinchao Hu, et al.
Frontiers in Neurology (2020) Vol. 10
Open Access | Times Cited: 288

Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
Nils Korte, Ross Nortley, David Attwell
Acta Neuropathologica (2020) Vol. 140, Iss. 6, pp. 793-810
Open Access | Times Cited: 258

Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
Xu‐Qiao Chen, William C. Mobley
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 247

Synaptic degeneration in Alzheimer disease
Makis Tzioras, Robert I. McGeachan, Claire S. Durrant, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 1, pp. 19-38
Closed Access | Times Cited: 246

Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?
Helena Targa Dias Anastacio, Natalie Matosin, Lezanne Ooi
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 192

Four-repeat tauopathies
Thomas W. Rösler, Amir Tayaranian Marvian, Matthias Brendel, et al.
Progress in Neurobiology (2019) Vol. 180, pp. 101644-101644
Closed Access | Times Cited: 183

Mitochondria and Calcium in Alzheimer’s Disease: From Cell Signaling to Neuronal Cell Death
Maria Calvo‐Rodriguez, Brian J. Bacskai
Trends in Neurosciences (2020) Vol. 44, Iss. 2, pp. 136-151
Closed Access | Times Cited: 179

Alzheimer’s pathology targets distinct memory networks in the ageing brain
Anne Maaß, David Berron, Theresa M. Harrison, et al.
Brain (2019) Vol. 142, Iss. 8, pp. 2492-2509
Open Access | Times Cited: 171

Emerging roles of innate and adaptive immunity in Alzheimer’s disease
Xiaoying Chen, David M. Holtzman
Immunity (2022) Vol. 55, Iss. 12, pp. 2236-2254
Open Access | Times Cited: 164

Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer’s Disease
Eleanor K. Pickett, Abigail G. Herrmann, Jamie McQueen, et al.
Cell Reports (2019) Vol. 29, Iss. 11, pp. 3592-3604.e5
Open Access | Times Cited: 147

Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology
Fernando Maestú, Willem de Haan, Marc Aurel Busche, et al.
Ageing Research Reviews (2021) Vol. 69, pp. 101372-101372
Open Access | Times Cited: 147

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 146

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Moxin Wu, Manqing Zhang, Xiaoping Yin, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 126

Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
Roberta Cascella, Cristina Cecchi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4914-4914
Open Access | Times Cited: 120

Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease
Marcos Otero-García, Sameehan Mahajani, Debia Wakhloo, et al.
Neuron (2022) Vol. 110, Iss. 18, pp. 2929-2948.e8
Open Access | Times Cited: 117

Mechanisms of sex differences in Alzheimer’s disease
Chloe Lopez-Lee, Eileen Ruth S. Torres, Gillian Carling, et al.
Neuron (2024) Vol. 112, Iss. 8, pp. 1208-1221
Open Access | Times Cited: 85

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight
Jacob W. Vogel, Nick Corriveau‐Lecavalier, Nicolai Franzmeier, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 10, pp. 620-639
Closed Access | Times Cited: 74

Page 1 - Next Page

Scroll to top